Heliosonix digitizes medical imaging (Smart HD vs. cathode ray tube TV) and seeks to popularize it through HaaS (hardware-as-a-service) model. Our optoacoustic imaging technology has been validated. We generate revenue with our in-vivo animal imaging product: $600K in 2020 & $20M funnel of $2.5B+ TAM. Our clinical targets include cancer & stroke diagnostics with $10B+ TAM: We have multiple shots on goal to launch a $1B+ product.